Finally, in the T-ALL context, Notch3-ICD undergoes deacetylation by HDAC1, favoring tumor development and progression in a Notch3-induced transgenic mouse model of T-ALL [69]. The gene discussed is NOTCH3; the disease is acute lymphoblastic leukemia.